BioXcel planning pivotal trial of BXCL501 for Alzheimer's agitation
BioXcel plans to test BXCL501 for treating agitation in Alzheimer’s disease dementia in patients in nursing and assisted living facilities.| Alzheimer's News Today
Blooming (or pre-infusing) filter coffee is an essential part of the brewing process: it’s when water first comes into contact with the coffee grounds. Many baristas use water-to-coffee ratios of 2:1 to 4:1 to allow enough carbon dioxide to be released from the grounds. However, there’s little agreement on what should happen next. Some consider […] The post Swirl, stir, or leave the bloom: Has specialty coffee decided what’s best? appeared first on Perfect Daily Grind.| Perfect Daily Grind
Even though I’m very aware this happens, this shockingly eye-opening article by Lydia Green is the best explanation I’ve heard…. I didn’t set out to shape the field of psychiatry. I was just a copywriter working in pharmaceutical advertising. But over time, I found myself at the center of a campaign that would help transform […] The post The marketing of Risperdal and how atypical antipsychotics became a multi-billion-dollar industry – a shockingly eye-opening article! appeared ...| everywomanover29 blog
BioXcel plans to test BXCL501 for treating agitation in Alzheimer’s disease dementia in patients in nursing and assisted living facilities.| Alzheimer's News Today
The company recently announced results from two Phase 3 trials of AXS-05 for agitation. ACCORD-2, hit its main goal, but ADVANCE-2 didn't.| Alzheimer's News Today
